ハギワラ　ノブヒサ   Nobuhisa Hagiwara   萩原　誠久    所属   その他 その他    職種   非常勤嘱託
論文種別	原著
言語種別	英語
査読の有無	査読あり
表題	Outcomes of Renal Transplant Recipients after Percutaneous Coronary Intervention.
掲載誌名	正式名：The American journal of cardiology 略　 称：Am J Cardiol ISSNコード：0002-9149/1879-1913
掲載区分	国外
出版社	Elsevier B.V.
巻・号・頁	pp.in press
著者・共著者	NAKAO Masashi†, YAMAGUCHI Junichi*, SATOMI Natsuko, EBIHARA Suguru, TANAKA Kazuki, OOTSUKI Hisao, INAGAKI Yusuke, JUJO Kentaro, ARASHI Hiroyuki, HAGIWARA Nobuhisa
担当区分	最終著者
発行年月	2020/02
概要	Renal transplantation (RT) can improve life expectancy in hemodialysis (HD) patients. However, little is known about the outcomes of renal transplant recipients after percutaneous coronary intervention (PCI). This study aimed to elucidate the effect of RT on clinical outcomes after PCI. Renal transplant recipients who underwent PCI from 2002 to 2017 were enrolled. To evaluate the effectiveness of RT, we retrospectively reviewed HD patients who underwent PCI. Propensity-score matching was performed using logistic regression to control for differences in baseline characteristics. The primary outcome was the incidence of major adverse cardiac events. After propensity matching, patients were classified into the RT (n = 50) group and HD (n = 50) group. Kaplan-Meier analysis revealed that the incidence of major adverse cardiac events was significantly lower in the RT group than in the HD group (p < 0.0001). Moreover, RT was associated with a lower risk for all-cause death (odds ratio 0.04; 95% confidence interval 0.002 to 0.03; p = 0.0054) and target vessel revascularization (OR 0.27; 95% CI 0.07 to 0.79; p = 0.015). RT may improve clinical outcomes after PCI, and it is encouraged for HD patients to increase life expectancy and reduce the occurrence of adverse events after PCI. Further research would be warranted to support this finding.
DOI	10.1016/j.amjcard.2020.02.007
PMID	32139159